Simona Barbuto Ferraiuolo

Mrs. Simona Barbuto Ferraiuolo

University of Campania "Luigi Vanvitelli" Department of Experimental Medicine
+1
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
SFSimona Barbuto Ferraiuolo
Simona Barbuto Ferraiuolo
MCMarcella Cammarota
Marcella Cammarota
CSChiara Schiraldi
Chiara Schiraldi
Odile Francesca RestainoOdile Francesca Restaino
Odile Francesca Restaino

20 June 2019 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Odile Francesca RestainoOdile Francesca Restaino
Odile Francesca Restaino
SDSergio D'ambrosio
Sergio D'ambrosio
ECElisabetta Cassese
Elisabetta Cassese
SFSimona Barbuto Ferraiuolo
Simona Barbuto Ferraiuolo
AAAlberto Alfano
Alberto Alfano
Donatella CiminiDonatella Cimini
Donatella Cimini

6 August 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SDS. D’ambrosio
S. D’ambrosio
AAA. Alfano
A. Alfano
ECE. Cassese
E. Cassese
ORO. F. Restaino
O. F. Restaino
SFSimona Barbuto Ferraiuolo
Simona Barbuto Ferraiuolo
Donatella CiminiDonatella Cimini
Donatella Cimini
The capsular polysaccharide obtained from Escherichia coli K4 is a glycosaminoglycan-like molecule, similar to chondroitin sulphate, that has established applications in the biomedical field. Recent efforts focused on the development of strategies to increase K4 polysaccharide fermentation titers up to technologically attractive levels, but an aspect that has not been investigated so far, is how changes in the molecular machinery that produces this biopolymer affect its molecular weight. In this work, we took advantage of recombinant E. coli K4 strains that overproduce capsular polysaccharide, to study whether the inferred pathway modifications also influenced the size of the produced polymer. Fed-batch fermentations were performed up to the 22 L scale, in potentially industrially applicable conditions, and a purification protocol that allows in particular the recovery of high molecular weight unsulphated chondroitin, was developed next. This approach allowed to determine the molecular weight of the purified polysaccharide, demonstrating that kfoF overexpression increased polymer size up to 133 kDa. Higher polysaccharide titers and size were also correlated to increased concentrations of UDP-GlcA and decreased concentrations of UDP-GalNAc during growth. These results are interesting also in view of novel potential applications of higher molecular weight chondroitin and chondroitin sulphate in the biomedical field.

23 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Odile Francesca RestainoOdile Francesca Restaino
Odile Francesca Restaino
SFSimona Barbuto Ferraiuolo
Simona Barbuto Ferraiuolo
APAddolorata Perna
Addolorata Perna
MCMarcella Cammarota
Marcella Cammarota
MBMaria Giovanna Borzacchiello
Maria Giovanna Borzacchiello
chiara Schiraldichiara Schiraldi
chiara Schiraldi
16α-Hydroxyprednisolone, an anti-inflammatory drug, could be potentially obtained from hydrocortisone bioconversion by combining a 1,2-dehydrogenation reaction performed by Arthrobacter simplexATCC31652 with a 16α-hydroxylation reaction by Streptomyces roseochromogenes ATCC13400. In this study we tested, for the first time, potential approaches to couple the two reactions using similar pH and temperature conditions for hydrocortisone bioconversion by the two strains. The A. simplex capability to 1,2-dehydrogenate the 16α-hydroxyhydrocortisone, the product of S. roseochromogenes transformation of hydrocortisone, and vice versa the capability of S. roseochromogenes to 16α-hydroxylate the prednisolone were assessed. Bioconversions were studied in shake flasks and strain morphology changes were observed by SEM. Whole cell experiments were set up to perform the two reactions in a sequential mode in alternate order or contemporarily at diverse temperature conditions. A. simplex catalyzed either the dehydrogenation of hydrocortisone into prednisolone efficiently or of 16α-hydroxyhydrocortisone into 16α-hydroxyprednisolone in 24 h (up to 93.9%). Surprisingly S. roseochromogenes partially converted prednisolone back to hydrocortisone. A 68.8% maximum of 16α-hydroxyprednisolone was obtained in 120-h bioconversion by coupling whole cells of the two strains at pH 6.0 and 26 °C. High bioconversion of hydrocortisone into 16α-hydroxyprednisolone was obtained for the first time by coupling A. simplex and S. roseochromogenes.

21 August 2021 in Fermentation
Verified
Journal Article
Open access
PDF file
SFSimona Barbuto Ferraiuolo
Simona Barbuto Ferraiuolo
Odile Francesca RestainoOdile Francesca Restaino
Odile Francesca Restaino
IGIgnacio Gutiérrez-del-Río
Ignacio Gutiérrez-del-Río
RVRiccardo Ventriglia
Riccardo Ventriglia
MCMarcella Cammarota
Marcella Cammarota
chiara Schiraldichiara Schiraldi
chiara Schiraldi
Streptomyces albus J1074-pAPI (Streptomyces albus-pAPI) is a recombinant strain constructed to biotechnologically produce apigenin, a flavonoid with interesting bioactive features that up to now has been manufactured by extraction from plants with long and not environmentally friendly procedures. So far, in literature, only a maximum apigenin concentration of 80.0 µg·L−1 has been obtained in shake flasks. In this paper, three integrated fermentation strategies were exploited to enhance the apigenin production by Streptomyces albus J1074-pAPI, combining specific approaches for pre-inoculum conditions, optimization of fermentation process parameters and supplementation of precursors. Using a pre-inoculum of mycelium, the apigenin concentration increased of 1.8-fold in shake flask physiological studies. In 2L batch fermentation, the aeration and stirring conditions were optimized and integrated with the new inoculum approach and the apigenin production reached 184.8 ± 4.0 µg·L−1, with a productivity of 2.6 ± 0.1 μg·L−1·h−1. The supplementation of 1.5 mM L-tyrosine in batch fermentations allowed to obtain an apigenin production of 343.3 ± 3.0 µg·L−1 in only 48 h, with an increased productivity of 7.1 ± 0.1 μg·L−1·h−1. This work demonstrates that the optimization of fermentation process conditions is a crucial requirement to increase the apigenin concentration and productivity by up to 4.3- and 10.7-fold.

Verified
Journal Article
Open access
PDF file
ÁVÁlvaro Pérez Valero
Álvaro Pérez Valero
JDJuan Serna Diestro
Juan Serna Diestro
ARAlbert Tafur Rangel
Albert Tafur Rangel
SFSimona Barbuto Ferraiuolo
Simona Barbuto Ferraiuolo
chiara Schiraldichiara Schiraldi
chiara Schiraldi
FLFelipe Lombó
Felipe Lombó
Flavonoids exhibit various bioactivities including anti-oxidant, anti-tumor, anti-inflammatory, and anti-viral properties. Methylated flavonoids are particularly significant due to their enhanced oral bioavailability, improved intestinal absorption, and greater stability. The heterologous production of plant flavonoids in bacterial factories involves the need for enough biosynthetic precursors to allow for high production levels. These biosynthetic precursors are malonyl-CoA and l-tyrosine. In this work, to enhance flavonoid biosynthesis in Streptomyces albidoflavus, we conducted a transcriptomics study for the identification of candidate genes involved in l-tyrosine catabolism. The hypothesis was that the bacterial metabolic machinery would detect an excess of this amino acid if supplemented with the conventional culture medium and would activate the genes involved in its catabolism towards energy production. Then, by inactivating those overexpressed genes (under an excess of l-tyrosine), it would be possible to increase the intracellular pools of this precursor amino acid and eventually the final flavonoid titers in this bacterial factory. The RNAseq data analysis in the S. albidoflavus wild-type strain highlighted the hppD gene encoding 4-hydroxyphenylpyruvate dioxygenase as a promising target for knock-out, exhibiting a 23.2-fold change (FC) in expression upon l-tyrosine supplementation in comparison to control cultivation conditions. The subsequent knock-out of the hppD gene in S. albidoflavus resulted in a 1.66-fold increase in the naringenin titer, indicating enhanced flavonoid biosynthesis. Leveraging the improved strain of S. albidoflavus, we successfully synthesized the methylated flavanones hesperetin, homoeriodictyol, and homohesperetin, achieving titers of 2.52 mg/L, 1.34 mg/L, and 0.43 mg/L, respectively. In addition, the dimethoxy flavanone homohesperetin was produced as a byproduct of the endogenous metabolism of S. albidoflavus. To our knowledge, this is the first time that hppD deletion was utilized as a strategy to augment the biosynthesis of flavonoids. Furthermore, this is the first report where hesperetin and homoeriodictyol have been synthesized from l-tyrosine as a precursor. Therefore, transcriptomics is, in this case, a successful approach for the identification of catabolism reactions affecting key precursors during flavonoid biosynthesis, allowing the generation of enhanced production strains.